RDNT insider filing: 35,000 shares planned sale via Merrill Lynch
Rhea-AI Filing Summary
Form 144 notice for RadNet, Inc. (RDNT): The filer notified the SEC of a proposed sale of 35,000 common shares on 09/15/2025 through Merrill Lynch (Chandler, AZ) on NASDAQ, with an aggregate market value of $2,590,350.00. The shares were acquired as equity compensation in multiple grants dated between 01/02/2014 and 01/03/2017, totaling listed lots of 8,353; 12,018; 12,982; 1,638; and 9 shares. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Full disclosure filed: The filer submitted a Form 144 specifying broker, share count, and aggregate market value.
- Securities originated from equity compensation: Acquisition rows list employee/equity compensation grants dated 2013–2017.
- No recent sales: The filer reported "Nothing to Report" for securities sold during the past three months.
Negative
- None.
Insights
TL;DR: Routine Form 144 filing disclosing a planned sale of 35,000 RDNT shares acquired via equity compensation.
This filing is a standard Rule 144 notice documenting an intended sale by an insider or person subject to Rule 144 aggregation rules. Key facts are the 35,000-share block, the $2,590,350 aggregate market value, the broker (Merrill Lynch, Chandler AZ), and the scheduled sale date of 09/15/2025. The acquisition rows show the shares were granted as employee/equity compensation across grants dated 2013–2017, which supports that the shares are vesting/granted stock rather than open-market purchases. The filing states there were no sales in the past three months by the account.
TL;DR: Disclosure aligns with insider-sale reporting requirements; nothing in the form indicates undisclosed company developments.
The document contains the required seller representation that no material nonpublic information exists. The granular acquisition dates and nature (employee compensation) are provided, which helps investors and compliance officers trace the holding period and Rule 144 eligibility. The filing does not include any indication of related-party transactions beyond compensation-originated grants.